Basilea Pharmaceutica AG
BPMUF
$67.75
$6.4110.45%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.58M | 8.79M | 32.37M | 32.87M | 11.47M |
| Total Depreciation and Amortization | 526.10K | 482.80K | 1.43M | 1.45M | 402.00K |
| Total Amortization of Deferred Charges | 282.50K | 259.20K | 244.80K | 248.60K | 259.90K |
| Total Other Non-Cash Items | 3.96M | 3.64M | -1.98M | -2.01M | -5.63M |
| Change in Net Operating Assets | -376.40K | -345.40K | 75.20K | 76.30K | 3.41M |
| Cash from Operations | 13.98M | 12.82M | 32.14M | 32.63M | 9.91M |
| Capital Expenditure | -194.60K | -178.50K | -707.70K | -718.50K | -258.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 0.00 | 0.00 | 431.80K |
| Other Investing Activities | -56.40K | -51.70K | -16.50K | -16.80K | -29.30K |
| Cash from Investing | -250.90K | -230.30K | -724.20K | -735.30K | 144.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | -7.80M |
| Issuance of Common Stock | 253.50K | 253.50K | 73.50K | 73.50K | 1.16M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.49M | -7.49M | -84.50K | -84.50K | 74.00K |
| Cash from Financing | -8.77M | -8.05M | -12.50K | -12.70K | -7.27M |
| Foreign Exchange rate Adjustments | -6.70K | -6.10K | -33.60K | -34.10K | 60.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.95M | 4.54M | 31.37M | 31.85M | 2.85M |